Page last updated: 2024-09-04

celastrol methyl ester and angiotensin ii

celastrol methyl ester has been researched along with angiotensin ii in 1 studies

Compound Research Comparison

Studies
(celastrol methyl ester)
Trials
(celastrol methyl ester)
Recent Studies (post-2010)
(celastrol methyl ester)
Studies
(angiotensin ii)
Trials
(angiotensin ii)
Recent Studies (post-2010) (angiotensin ii)
3902738,1521,0897,413

Protein Interaction Comparison

ProteinTaxonomycelastrol methyl ester (IC50)angiotensin ii (IC50)
Atrial natriuretic peptide receptor 3Homo sapiens (human)0.002
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.002
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0018
Type-1 angiotensin II receptorHomo sapiens (human)0.0055
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.004
Type-2 angiotensin II receptorHomo sapiens (human)0.0011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bao, X; Feng, J; Jing, Z; Lu, Y; Wu, M; Zeng, Z1

Other Studies

1 other study(ies) available for celastrol methyl ester and angiotensin ii

ArticleYear
Pristimerin protects against pathological cardiac hypertrophy through improvement of PPARĪ± pathway.
    Toxicology and applied pharmacology, 2023, Aug-15, Volume: 473

    Topics: Angiotensin II; Animals; Cardiomegaly; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; PPAR alpha; Rats; Signal Transduction

2023